Giovanni Mambrini
Directeur Technique/Scientifique/R&D chez QUINCE THERAPEUTICS, INC.
Profil
Giovanni Mambrini was the founder of EryDel SpA, a company founded in 2008, where he held the title of Chief Operating Officer from 2012 to 2023.
He is currently working as the Chief Technology Officer at Quince Therapeutics, Inc. since 2023.
In his former positions, he worked as a Principal at Sorin SpA and as a Manager-Research & Development at Covidien Italia SpA from 1998 to 2002.
He also held the position of Manager-Scientific Affairs at Sorin Group Italia Srl.
Dr. Mambrini completed his graduate degree at Alma Mater Studiorum - Università di Bologna.
Postes actifs de Giovanni Mambrini
| Sociétés | Poste | Début |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2023 |
Anciens postes connus de Giovanni Mambrini
| Sociétés | Poste | Fin |
|---|---|---|
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Fondateur | 01/10/2023 |
Covidien Italia SpA
 Covidien Italia SpA Medical SpecialtiesHealth Technology Covidien Italia SpA manufactures and supplies medical devices, surgical instruments, respiratory monitoring tools and vascular therapies. The company is headquartered in Segrate, Italy. | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Sorin Group Italia Srl
 Sorin Group Italia Srl Medical SpecialtiesHealth Technology MicroPort CRM SRL engages in the production and distribution of medical devices. It specializes in the development of medical technologies for the treatment of cardiovascular diseases. The company is headquartered in Saluggia, Italy. | Corporate Officer/Principal | - |
| SORIN SPA | Corporate Officer/Principal | - |
Formation de Giovanni Mambrini
| Alma Mater Studiorum - Università di Bologna | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Sorin SpA
 Sorin SpA Medical SpecialtiesHealth Technology Sorin SpA engages in the research, development, and manufacture of technology products for the treatment of cardiovascular diseases. It operates through the Cardiac Surgery and Cardiac Rhythm business segments. The Cardiac Surgery segment involves in the production and marketing of single-use biomedical devices, systems used to ensure out-of-body circulation in cardiac surgical procedures, and implantable prosthetics to replace or repair heart valves. The Cardiac Rhythm segment deals with the production and marketing of implantable devices and monitoring equipment and accessories to protect against heartbeat disorders. The company was founded in 1956 and is headquartered in Milan, Italy. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
Covidien Italia SpA
Covidien Italia SpA Medical SpecialtiesHealth Technology Covidien Italia SpA manufactures and supplies medical devices, surgical instruments, respiratory monitoring tools and vascular therapies. The company is headquartered in Segrate, Italy. | Health Technology |
Sorin Group Italia Srl
Sorin Group Italia Srl Medical SpecialtiesHealth Technology MicroPort CRM SRL engages in the production and distribution of medical devices. It specializes in the development of medical technologies for the treatment of cardiovascular diseases. The company is headquartered in Saluggia, Italy. | Health Technology |
